Patrick G. LePore

Independent Vice Chairman at Matinas BioPharma Holdings, Inc.

Patrick G. LePore

Patrick G. LePore

Independent Vice Chairman at Matinas BioPharma Holdings, Inc.

Overview
Career Highlights

Cardinal Health, Inc.
Par Pharmaceutical Companies, Inc.
Par Pharmaceutical, Inc.

RelSci Relationships

2012

Number of Boards

12

Birthday

1955

Age

65

Relationships
RelSci Relationships are individuals Patrick G. LePore likely has professional access to. A relationship does not necessarily indicate a personal connection.

General Counsel at Par Pharmaceutical Companies, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Endo Health Solutions, Inc.

Relationship likelihood: Strong

President at Villanova University

Relationship likelihood: Strong

Director & Partner at Florida Cancer Specialists & Research Institute LLC

Relationship likelihood: Strong

Founder at AgeneBio, Inc.

Relationship likelihood: Strong

Former Governor of Wisconsin

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Avara Norman Pharmaceutical Services, Inc.

Relationship likelihood: Strong

Co-President at Global Health Associates LLC

Relationship likelihood: Strong

Chief Financial Officer & Executive Vice President at Par Pharmaceutical, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer & Director at Andrx Corp.

Relationship likelihood: Strong

Paths to Patrick G. LePore
Potential Connections via
Relationship Science
You
Patrick G. LePore
Independent Vice Chairman at Matinas BioPharma Holdings, Inc.
Career History
Independent Vice Chairman
Current

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling the delivery of life-changing medicines using its LNC platform technology. The company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins, and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. Its anti-fungal product candidate, MAT2203, delivers broad-spectrum fungicidal agent, amphotericin B, and is being developed to prevent invasive fungal infections in patients with acute lymphoblastic leukemia. The company was founded by Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

Chief Executive Officer & President
2006 - Prior
Chairman, President & Chief Executive Officer
2006 - 2012

Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY.

Boards & Committees
Director
2015 - Current
Chairman, Board of Directors
2013 - Current
Independent Director
2015 - Prior
Political Donations
$10K
2012
$1,300
2008
$500
2004
Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Patrick G. LePore. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Patrick G. LePore's profile does not indicate a business or promotional relationship of any kind between RelSci and Patrick G. LePore.